- Report
- April 2025
- 175 Pages
Global
From €4112EUR$4,490USD£3,501GBP
Avonex is a drug used to treat musculoskeletal disorders, such as multiple sclerosis (MS). It is a recombinant interferon beta-1a, which is a type of protein that helps to reduce inflammation and slow the progression of MS. Avonex is administered by intramuscular injection once a week. It is used to reduce the frequency of relapses and slow the progression of disability in people with relapsing forms of MS.
Avonex is one of several drugs used to treat MS, and is one of the most commonly prescribed medications for the condition. It is approved for use in more than 90 countries, and is available in both generic and branded forms.
The market for musculoskeletal disorder drugs is highly competitive, with many companies offering similar products. Some of the major players in the market include Biogen, Merck, Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more